These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7104158

  • 21. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ, Jaguste V, Nanivadekar AS.
    J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
    [Abstract] [Full Text] [Related]

  • 22. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF.
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [Abstract] [Full Text] [Related]

  • 23. Effect of prazosin and propranolol on lipoproteins of hypertensive patients.
    Hurt E, Velasco M, Silva H, Camejo G.
    Biomed Biochim Acta; 1987; 46(1):111-8. PubMed ID: 3107546
    [Abstract] [Full Text] [Related]

  • 24. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O.
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [Abstract] [Full Text] [Related]

  • 25. [Combination antihypertensive therapy in patients with an increased risk profile].
    Bartens W, Nauck M, Wanner C.
    Med Klin (Munich); 1996 Oct 15; 91(10):626-31. PubMed ID: 9019639
    [Abstract] [Full Text] [Related]

  • 26. Lipid profile during antihypertensive treatment. The SLIP Study Group. Study on Lipids with Isoptin Press.
    Libretti A, Catalano M.
    Drugs; 1993 Oct 15; 46 Suppl 2():16-23. PubMed ID: 7512469
    [Abstract] [Full Text] [Related]

  • 27. [Biochemical changes in hypertensive patients during a 1-year cross-over study of treatment with hydrochlorothiazide and propranolol].
    Bagatin J, Rumboldt Z, Polić S, Sardelić S, Ljutić D, Capkun V, Pivac N, Petrović P, Bojić L.
    Lijec Vjesn; 1996 Oct 15; 118(1-2):11-6. PubMed ID: 8759414
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the effect of indoramin and prazosin on blood pressure and lipid profiles in essential hypertension.
    Overlack A, Stumpe KO.
    J Cardiovasc Pharmacol; 1986 Oct 15; 8 Suppl 2():S53-5. PubMed ID: 2423798
    [Abstract] [Full Text] [Related]

  • 29. Concomitant considerations in long-term antihypertensive treatment.
    Holzgreve H, Middeke M.
    J Hum Hypertens; 1990 Dec 15; 4 Suppl 5():11-8. PubMed ID: 2090833
    [Abstract] [Full Text] [Related]

  • 30. [Biochemical plasma changes in essential hypertension patients treated for a year].
    Baños Gallardo M, Argüelles Toraño M, Rojo Ortega JM.
    Rev Clin Esp; 1989 Apr 15; 184(7):347-51. PubMed ID: 2772309
    [Abstract] [Full Text] [Related]

  • 31. Serum lipids and glucose concentrations in subjects using antihypertensive drugs: Finnmark 1977.
    Arnesen E, Thelle DS, Førde OH, Mjøs OD.
    J Epidemiol Community Health; 1983 Jun 15; 37(2):141-4. PubMed ID: 6886585
    [Abstract] [Full Text] [Related]

  • 32. Effect of antihypertensive therapy on plasma lipids and lipoproteins in mild hypertension.
    Sagar S, Majumdar S, Sharma BK.
    Indian Heart J; 1989 Jun 15; 41(1):39-50. PubMed ID: 2737688
    [Abstract] [Full Text] [Related]

  • 33. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ, Nanivadekar AS.
    J Assoc Physicians India; 1998 Jun 15; Suppl 1():52-62. PubMed ID: 11233387
    [Abstract] [Full Text] [Related]

  • 34. [Comparative study of the effects of prazosin and atenolol on plasma lipids of hypertensive patients].
    Rouffy J, Jaillard J.
    Rev Med Interne; 1985 Jan 15; 6(1):77-81. PubMed ID: 3890049
    [Abstract] [Full Text] [Related]

  • 35. Adrenergic mechanisms in control of plasma lipid concentrations.
    Day JL, Metcalfe J, Simpson CN.
    Br Med J (Clin Res Ed); 1982 Apr 17; 284(6323):1145-8. PubMed ID: 6122483
    [Abstract] [Full Text] [Related]

  • 36. Effects of bunazosin and atenolol on serum lipids and apolipoproteins in a randomised trial.
    Schmitz G, Stumpe KO, Herrmann W, Weidinger G.
    Blood Press; 1996 Nov 17; 5(6):354-9. PubMed ID: 8973753
    [Abstract] [Full Text] [Related]

  • 37. Plasma lipid and lipoprotein changes in hypertensive patients treated with propranolol and prazosin.
    Gemma G, Montanari G, Suppa G, Paralovo A, Franceschini G, Mantero O, Sirtori CR.
    J Cardiovasc Pharmacol; 1982 Nov 17; 4 Suppl 2():S233-7. PubMed ID: 6177963
    [Abstract] [Full Text] [Related]

  • 38. Improvement of the lipid profile during long-term administration of pindolol and hydrochlorothiazide in patients with hypertension.
    Samuel P, Chin B, Fenderson RW, Schoenfeld BH, Gonasun LM, Lieberman S.
    Am J Cardiol; 1986 Feb 12; 57(5):24C-28C. PubMed ID: 3946247
    [Abstract] [Full Text] [Related]

  • 39. [Changes in serum lipids during drug therapy of hypertension].
    Lohmann FW.
    Wien Med Wochenschr; 1982 Feb 12; 132 Spec No 2():6-14. PubMed ID: 6132498
    [No Abstract] [Full Text] [Related]

  • 40. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
    Talseth T, Westlie L, Daae LN.
    J Hypertens Suppl; 1990 Sep 12; 8(5):S47-51. PubMed ID: 1981077
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.